Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Bogotá’s strictest COVID restrictions delivered the clearest air-quality gains

21

Jun 2026

Bogotá’s strictest COVID restrictions delivered the clearest air-quality gains

A natural quasi-experiment in Suba, Bogotá, found that more stringent COVID-19 mobility restrictions were associated with larger reductions in PM₁₀ and PM₂.₅ air pollution. The findings suggest targeted traffic and emissions controls could improve urban air quality, although ozone responses were more complex, and the results may not generalize beyond this high-traffic district.

Google’s AMIE beats doctors on key simulated disease-management tasks

21

Jun 2026

Google’s AMIE beats doctors on key simulated disease-management tasks

Google’s AMIE research AI matched primary care physicians overall in simulated, multi-visit disease-management reasoning and scored higher on several measures of plan appropriateness, treatment precision, investigation precision, and guideline alignment. The study highlights the promise of conversational AI for longitudinal care, while emphasizing that AMIE is not ready for clinical use and still needs prospective real-world testing.

Synthetic gut communities reveal how diet rewires the microbiome

21

Jun 2026

Synthetic gut communities reveal how diet rewires the microbiome

Synthetic microbial communities give researchers controlled models for testing how diet reshapes gut microbial ecology, metabolism, and host-relevant responses. The review highlights how SynComs can strengthen causal inference, improve intervention testing, and support future precision nutrition, while noting major challenges in stability, standardization, and ecological realism.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.